Launched proprietary AI agent for secure browser automation.
“Launched proprietary AI agent for secure browser automation, marking a significant milestone in the Company’s AI strategy.”
Reliance Global Group, Inc.EZRA
AI agent disclosures in SEC filings, deployment confirmed
As of 2026-08-04, Reliance Global Group, Inc. (EZRA) disclosed AI-agent language in 1 SEC filing since 2026-08-04, including 2 excerpts describing its own deployment of AI agents (source: Agentic 10-K, from SEC EDGAR).
- Stage
- Deployed
- Market cap
- $4MYahoo Finance, 2026-10-21
- First seen
- 2026-08-04
- Latest filing
- 2026-08-04
Matching filings by quarter
What the filings cover
Functions named
IT & security ops, Legal & compliance
Vendors and products named
None named
Source
1 filing since 2025-01-01. All EDGAR filings (opens in a new tab)
Stage and function are keyword-rule labels, not the company’s words.
In its own words
Sentences copied from the filings, whitespace normalised.
“Launched proprietary AI agent for secure browser automation, marking a significant milestone in the Company’s AI strategy.”
“In July, Reliance announced the successful launch of its proprietary AI agent for secure browser automation.”
“, the satisfaction of milestones under the related share purchase agreement, the Company’s ability to acquire a majority or controlling interest in Enquantum, and the development, commercialization, and market adoption of Enquantum’s post-quantum cybersecurity technologies; the Company’s investment in Innervate Radiopharmaceuticals LLC and the development and potential commercialization of Innervate’s positron…”
All matching filings
8-K filed 2026-08-04 Filing index (opens in a new tab)
Announced successful launch of proprietary AI agent for secure browser automation.
“In July, Reliance announced the successful launch of its proprietary AI agent for secure browser automation. The AI solution is designed to securely automate complex web-based workflows while maintaining enterprise-grade security and compliance standards. The platform represents a significant milestone in the Company’s ongoing strategy to leverage proprietary artificial intelligence to enhance operational performance, improve scalability and create new long-term growth opportunities.”
Forward-looking statements include development and deployment of proprietary AI technologies including AI agent.
“Forward-looking statements in this press release include, without limitation, statements regarding: the Company’s strategic plans, including its Scale51 strategy and the activities of EZRA International Group and LifeSci Global Group; the Company’s ability to identify, invest in, integrate, scale, and obtain controlling interests in technology and life sciences businesses, including the timing and likelihood thereof; the Company’s investment in Enquantum Ltd., the satisfaction of milestones under the related share purchase agreement, the Company’s ability to acquire a majority or controlling interest in Enquantum, and the development, commercialization, and market adoption of Enquantum’s post-quantum cybersecurity technologies; the Company’s investment in Innervate Radiopharmaceuticals LLC and the development and potential commercialization of Innervate’s positron emission tomography imaging and therapeutic radiopharmaceutical product candidates, including for the treatment of neuroblastoma and potential future applications; the future operations and prospects of LifeSci Global Group LLC and any future investments to be made through that platform; the Company’s ability to maintain compliance with the minimum bid price requirement and other continued listing standards of The Nasdaq Capital Market; the development, deployment, expansion, and potential commercialization of the Company’s proprietary artificial intelligence technologies, including the Company’s AI agent for secure”